Novel application of NIH case definitions in a paediatric tuberculosis contact investigation study

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 4, 2015, Pages 446-453

  Wiseman, C A ^a   Mandalakas, A M ^a,b,c   Kirchner, H L ^d   Gie, R P ^a   Schaaf, H S ^a   Walters, E ^a   Hesseling, A C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

Author keywords

Case definition; Diagnosis; NIH; Paediatric; Tuberculosis

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIUM DETECTION; CHILD; CHILDHOOD DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; COINFECTION; COMPARATIVE STUDY; FEMALE; HIV INFECTIONS; MALE; PRESCHOOL CHILD; RISK FACTOR; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); RISK FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 84925688053     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0585     Document Type: Article

References (43)

1. Marais B J, Gie R P, Schaaf H S, Hesseling A C, Enarson D A, Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis 2006; 10: 732-738.
2. Marais B J, Donald P R, Gie R P, Schaaf H S, Beyers N. Diversity of disease in childhood pulmonary tuberculosis. Ann Trop Paediatr 2005; 25: 79-86.
3. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402.
4. Donald P R, Ahmed A, Burman WJ, et al. Requirements for the clinical evaluation of new anti-tuberculosis agents in children. Int J Tuberc Lung Dis 2013; 17: 794-799.
5. Wiseman C A, Gie R P, Starke J R, et al. A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J 2012; 31: 347-352.
6. Weber H C, Beyers N, Gie R P, Schaaf H S, Fish T, Donald P R. The clinical and radiological features of tuberculosis in adolescents. Ann Trop Paediatr 2000; 20: 5-10.
7. Graham S M, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus From an Expert Panel. J Infect Dis 2012; 2012 (Suppl 2): S199-S208.
8. Marais B J, Hesseling A C, Gie R P, Schaaf H S, Enarson D A, Beyers N. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006; 42: e69-71.
9. Kritzinger F E, den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009; 14: 136-142.
10. Marais B J, Gie R P, Hesseling A C, Schaaf H S, Enarson D A, Beyers N. Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. Pediatr Infect Dis J 2006; 25: 237-240.
11. Marais B J, Gie R P, Hesseling A C, et al. A refined symptombased approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006; 118: e1350-1359.
12. Mandalakas A, Kirchner H L, Lombard C, Walzyl G, Gie R P, Hesseling A C. Well quantified TB exposure is a reliable surrogate measure oftuberculosis infection in children. Int J Tuberc Lung Dis 2012; 16 1033-1039.
13. Mandalakas A M, Hesseling A C. The utility of interferongamma release assays in TB-HIV co-infected children: what does the future hold? Int J Tuberc Lung Dis 2011; 15: 1423-1424.
14. Marais B J, Gie R P, Schaaf H S, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34: 886-894.
15. Lalvani A, Pathan A A, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-828.
16. Connell T G, Rangaka M X, Curtis N, Wilkinson R J. Quanti FERON®-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev Mol Diagn 2006; 6: 663-677.
17. Mandalakas A M, van Wyk S, Kirchner H L, et al. Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J 2013; 32: e111-118.
18. Marais B J, Gie R P, Obihara C C, Hesseling A C, Schaaf H S, Beyers N. Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child 2005; 90: 1162-1165.
19. Cuevas L E, Browning R, Bossuyt P, et al. Evaluation of tuberculosis diagnostics in children: 2. Methodological Issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus From an Expert Panel. J Infect Dis 2012; 205 (Suppl 2): S209-S215.
20. Lee J J, Suo J, Lin C B, Wang J D, Lin T Y, Tsai Y C. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 2003; 7: 569-574.
21. Zaruba R, Kralova M. [Evaluation of the effectiveness of the BACTEC MGIT automatic system for culture of mycobacteria in comparison with classical methods of culture. Experience after one year of use]. Epidemiol Mikrobiol Imunol 2002; 51: 66-70. [Czech]
22. Ardito F, Sanguinetti M, Sechi L, et al. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis. New Microbiol 2000; 23: 151-158.
23. Badak F Z, Kiska D L, Setterquist S, Hartley C, O'Connell MA, Hopfer R L. Comparison of mycobacteria growth indicator tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens. J Clin Microbiol 1996; 34: 2236-2239.
24. Flanagan P G, Williams R, Paull A. Comparison of two automated systems for the isolation of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis 1999; 18: 912-914.
25. Hanna B A, Ebrahimzadeh A, Elliott L B, et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999; 37: 748-752.
26. Tortoli E, Cichero P, Piersimoni C, Simonetti M T, Gesu G, Nista D. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol 1999; 37: 3578-3582.
27. Tsuyuguchi K, Ikeda T, Nakatani K, Tsuboi T, Sato A, Kurasawa T. [Evaluation of the Mycobacteria Growth Indicator Tube system for detection and quantification of mycobacteria from clinical specimens]. Kekkaku 2003; 78: 389-393. [Japanese]
28. Whyte T, Cormican M, Hanahoe B, Doran G, Collins T, Corbett-Feeney G. Comparison of BACTEC MGIT 960 and BACTEC 460 for culture of Mycobacteria. Diagn Microbiol Infect Dis 2000; 38: 123-126.
29. Carroll N M, Richardson M, van Helden P D. Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratories. J Clin Microbiol 2003; 41: 2269; author reply 269-270.
30. Republic of South Africa Department of Health. South African National Tuberculosis Management Guidelines, 2009. Pretoria, South Africa: DoH, 2009. http://familymedicine.ukzn.ac.za/Libraries/Guidelines-Protocols/TB-Guidelines-2009.sflb.ashx. Accessed February 2015.
31. th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2010. http://www.whoint/tb/publications/2010/9789241547833/en/indexhtml Accessed January 2015.
32. Hatherill M, Verver S, Mahomed H. Consensus statement on diagnostic end points for infant tuberculosis vaccine trials. Clin Infect Dis 2012; 54: 493-501.
33. Schaaf H S, Marais B J, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7: 140.
34. Madhi S A, Huebner R E, Doedens L, Aduc T, Wesley D, Cooper P A. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000; 4: 448-454.
35. Bakeera-Kitaka S, Conesa-Botella A, Dhabangi A, et al. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis 2011; 15: 1082-1086.
36. Hesseling A C, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
37. Walters E, Cotton M F, Rabie H, Schaaf H S, Walters L O, Marais B J. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on antiretroviral therapy. BMC Pediatr 2008; 8: 1.
38. Madhi S A, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365: 21-31.
39. Van Wyk S S, Enarson D A, Beyers N, Lombard C, Hesseling A C. Consulting private health care providers aggravates treatment delay in urban South African tuberculosis patients. Int J Tuberc Lung Dis 2011; 15: 1069-1076.
40. Golub J E, Bur S, Cronin W A, et al. Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis 2006; 10: 24-30.
41. Van Wyk S S, Hamade H, Hesseling A C, Beyers N, Enarson D A, Mandalakas A M. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis 2010; 14: 650-653.
42. van Wyk S S, Reid A J, Mandalakas A M, et al. Operational challenges in managing isoniazid preventive therapy in child contacts: a high-burden setting perspective. BMC Public Health 2011; 11: 544.
43. rd Union World Conference on Lung Health, Kuala Lumpur, Malaysia, 15-19 November 2012. Int J Tuberc Lung Dis 2012; 16 (Suppl): S64.